{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:21:52Z","timestamp":1778494912302,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"7-8","license":[{"start":{"date-parts":[[2002,9,23]],"date-time":"2002-09-23T00:00:00Z","timestamp":1032739200000},"content-version":"vor","delay-in-days":53,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:p>Sixty\u2010three<jats:italic>Staphylococcus aureus<\/jats:italic>isolates with a wide distribution in quantitative \u03b2\u2010lactamase production were tested in vitro against amoxycillin and penicillin in combination with clavulanic acid to establish the influence of total amount of \u03b2\u2010lactamase present on the ability of clavulanic acid to protect against \u03b2\u2010lactamase degradation. The \u03b2\u2010lactamase stability of cefuroxime and dicloxacillin was also evaluated. MIC was determined by agar dilution using Mueller\u2010Hinton agar with both a conventional as well as a 100 times higher inoculum. The strains were tested both with and without induction of the \u03b2\u2010lactamase production. Clavulanic acid was highly effective in protecting against \u03b2\u2010lactamase degradation of both penicillin and amoxycillin. Even when using a high inoculum of strains with induced \u03b2\u2010lactamase production, all strains had MICs below the NCCLS breakpoint of 4\/2 mg\/l for amoxycillin\u2010clavulanic acid. Both cefuroxime and dicloxacillin were highly stable against staphylococcal \u03b2\u2010lactamase degradation. This study encourages further in vivo evaluation of amoxycillin\u2010clavulanic acid for severe staphylococcal infections.<\/jats:p>","DOI":"10.1034\/j.1600-0463.2002.11007807.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:26:05Z","timestamp":1047353165000},"page":"559-564","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro susceptibility of<i>Staphylococcus aureus<\/i>towards amoxycillin\u2010clavulanic acid, penicillin\u2010clavulanic acid, dicloxacillin and cefuroxime"],"prefix":"10.1111","volume":"110","author":[{"given":"ROBERT","family":"Skov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NIELS","family":"Frimodt\u2010M\u00d8Ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANK","family":"Espersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,9,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.1994.11741155"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345030-00004"},{"key":"e_1_2_1_4_2","first-page":"173","volume-title":"Infectious Diseases.","author":"Craig WA.","year":"1998"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/jcm.23.5.832-839.1986","article-title":"The role of betalactamase in staphylococcal resistance to penicil\u2010linase\u2010resistant penicillins and cephalosporins","volume":"23","author":"Mcdougal LK","year":"1986","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.3.435"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199039020-00008"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/32.3.431"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0195-6701(95)90151-5"},{"key":"e_1_2_1_10_2","first-page":"771","article-title":"Phage typing of staphylococci","volume":"24","author":"Blair JE","year":"1961","journal-title":"Bull WHO"},{"key":"e_1_2_1_11_2","first-page":"33","volume-title":"Staphylococci and Staphylococcal infections","author":"Parker MT.","year":"1983"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.4.781"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1997.9.3.167"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.5.989"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/27.1.117"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.5.755"},{"issue":"2","key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/19739478.1994.12314796","article-title":"The efficacy of amoxycillin\/clavulanate (Augmentin) in the treatment of severe staphylococcal infections","author":"Moreillon P.","year":"1994","journal-title":"J Chemother"},{"key":"e_1_2_1_18_2","volume-title":"Performance standards for antimicrobial disk susceptibility tests;Approved Standard \u2010 M2\u2010A7","author":"National Committee for Clinical Laboratory Standards.","year":"2000"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2591"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/514231"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1989.tb00779.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.4.669"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0463.2002.11007807.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0463.2002.11007807.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T08:03:09Z","timestamp":1704614589000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0463.2002.11007807.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":21,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1034\/j.1600-0463.2002.11007807.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0463.2002.11007807.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"2002-09-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}